12.5 USD
+0.11 (+0.89%)
12.5 USD
0 (0%)
Taking everything into account, EMBC scores 6 out of 10 in our fundamental rating. EMBC was compared to 185 industry peers in the Health Care Equipment & Supplies industry. EMBC scores excellent on profitability, but there are some minor concerns on its financial health. EMBC may be a bit undervalued, certainly considering the very reasonable score on growth
1. Profitability
1.1 Basic Checks
EMBC had positive earnings in the past year.
In the past year EMBC had a positive cash flow from operations.
In the past 5 years EMBC has always been profitable.
EMBC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
EMBC has a Return On Assets of 8.75%. This is amongst the best in the industry. EMBC outperforms 90.81% of its industry peers.
EMBC's Return On Invested Capital of 27.81% is amongst the best of the industry. EMBC outperforms 98.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EMBC is significantly above the industry average of 8.84%.
The last Return On Invested Capital (27.81%) for EMBC is above the 3 year average (22.63%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.75% | ||
| ROE | N/A | ||
| ROIC | 27.81% |
ROA(3y)6.88%
ROA(5y)18.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)22.63%
ROIC(5y)31.94%
1.3 Margins
The Profit Margin of EMBC (8.83%) is better than 81.62% of its industry peers.
In the last couple of years the Profit Margin of EMBC has declined.
Looking at the Operating Margin, with a value of 30.50%, EMBC belongs to the top of the industry, outperforming 97.30% of the companies in the same industry.
EMBC's Operating Margin has declined in the last couple of years.
EMBC's Gross Margin of 63.85% is fine compared to the rest of the industry. EMBC outperforms 65.95% of its industry peers.
In the last couple of years the Gross Margin of EMBC has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.5% | ||
| PM (TTM) | 8.83% | ||
| GM | 63.85% |
OM growth 3Y-5.72%
OM growth 5Y-7.43%
PM growth 3Y-23.59%
PM growth 5Y-25.86%
GM growth 3Y-2.36%
GM growth 5Y-1.89%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EMBC is creating value.
The number of shares outstanding for EMBC has been increased compared to 1 year ago.
The number of shares outstanding for EMBC has been increased compared to 5 years ago.
EMBC has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.07 indicates that EMBC is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.07, EMBC is in the better half of the industry, outperforming 61.08% of the companies in the same industry.
EMBC has a debt to FCF ratio of 7.84. This is a slightly negative value and a sign of low solvency as EMBC would need 7.84 years to pay back of all of its debts.
EMBC has a better Debt to FCF ratio (7.84) than 74.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.84 | ||
| Altman-Z | 2.07 |
ROIC/WACC3.33
WACC8.35%
2.3 Liquidity
A Current Ratio of 2.41 indicates that EMBC has no problem at all paying its short term obligations.
EMBC has a Current ratio (2.41) which is in line with its industry peers.
A Quick Ratio of 1.73 indicates that EMBC should not have too much problems paying its short term obligations.
EMBC has a Quick ratio of 1.73. This is comparable to the rest of the industry: EMBC outperforms 48.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.73 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 20.24% over the past year.
Measured over the past years, EMBC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -26.21% on average per year.
EMBC shows a decrease in Revenue. In the last year, the revenue decreased by -3.80%.
EMBC shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.10% yearly.
EPS 1Y (TTM)20.24%
EPS 3Y-25.33%
EPS 5Y-26.21%
EPS Q2Q%11.11%
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y-1.47%
Revenue growth 5Y-0.1%
Sales Q2Q%-7.72%
3.2 Future
The Earnings Per Share is expected to grow by 0.66% on average over the next years.
Based on estimates for the next years, EMBC will show a small growth in Revenue. The Revenue will grow by 1.59% on average per year.
EPS Next Y-0.06%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue Next Year0%
Revenue Next 2Y0.05%
Revenue Next 3Y0.21%
Revenue Next 5Y1.59%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 4.21, which indicates a rather cheap valuation of EMBC.
Based on the Price/Earnings ratio, EMBC is valued cheaper than 98.92% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.92. EMBC is valued rather cheaply when compared to this.
EMBC is valuated cheaply with a Price/Forward Earnings ratio of 4.21.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EMBC indicates a rather cheap valuation: EMBC is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.57, EMBC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.21 | ||
| Fwd PE | 4.21 |
4.2 Price Multiples
98.38% of the companies in the same industry are more expensive than EMBC, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, EMBC is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.01 | ||
| EV/EBITDA | 5.23 |
4.3 Compensation for Growth
The decent profitability rating of EMBC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.71%
EPS Next 3Y0.66%
5. Dividend
5.1 Amount
EMBC has a Yearly Dividend Yield of 5.05%, which is a nice return.
EMBC's Dividend Yield is rather good when compared to the industry average which is at 0.20. EMBC pays more dividend than 99.46% of the companies in the same industry.
EMBC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.05% |
5.2 History
EMBC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years2
5.3 Sustainability
36.69% of the earnings are spent on dividend by EMBC. This is a low number and sustainable payout ratio.
DP36.69%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
12.5
+0.11 (+0.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners99.49%
Inst Owner Change0%
Ins Owners1.29%
Ins Owner Change28.53%
Market Cap731.38M
Revenue(TTM)1.08B
Net Income(TTM)95.40M
Analysts51.11
Price Target17 (36%)
Short Float %5.84%
Short Ratio5.72
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.05% |
Yearly Dividend0.6
Dividend Growth(5Y)N/A
DP36.69%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.51%
Min EPS beat(2)-8.66%
Max EPS beat(2)41.68%
EPS beat(4)3
Avg EPS beat(4)26.75%
Min EPS beat(4)-8.66%
Max EPS beat(4)44.01%
EPS beat(8)7
Avg EPS beat(8)35.11%
EPS beat(12)9
Avg EPS beat(12)26.08%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.77%
Min Revenue beat(2)-2.58%
Max Revenue beat(2)4.13%
Revenue beat(4)2
Avg Revenue beat(4)0.59%
Min Revenue beat(4)-2.58%
Max Revenue beat(4)4.13%
Revenue beat(8)5
Avg Revenue beat(8)1.57%
Revenue beat(12)9
Avg Revenue beat(12)1.87%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.96%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.47%
Revenue NQ rev (1m)-1.15%
Revenue NQ rev (3m)-2.83%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.21 | ||
| Fwd PE | 4.21 | ||
| P/S | 0.68 | ||
| P/FCF | 4.01 | ||
| P/OCF | 3.82 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.23 |
EPS(TTM)2.97
EY23.76%
EPS(NY)2.97
Fwd EY23.75%
FCF(TTM)3.12
FCFY24.94%
OCF(TTM)3.28
OCFY26.21%
SpS18.47
BVpS-11.12
TBVpS-11.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.75% | ||
| ROE | N/A | ||
| ROCE | 39.73% | ||
| ROIC | 27.81% | ||
| ROICexc | 38.19% | ||
| ROICexgc | 39.66% | ||
| OM | 30.5% | ||
| PM (TTM) | 8.83% | ||
| GM | 63.85% | ||
| FCFM | 16.88% |
ROA(3y)6.88%
ROA(5y)18.78%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)22.63%
ROIC(5y)31.94%
ROICexc(3y)32.83%
ROICexc(5y)43.39%
ROICexgc(3y)34.19%
ROICexgc(5y)45.56%
ROCE(3y)32.33%
ROCE(5y)45.63%
ROICexgc growth 3Y-16%
ROICexgc growth 5Y-7.86%
ROICexc growth 3Y-15.5%
ROICexc growth 5Y-7.62%
OM growth 3Y-5.72%
OM growth 5Y-7.43%
PM growth 3Y-23.59%
PM growth 5Y-25.86%
GM growth 3Y-2.36%
GM growth 5Y-1.89%
F-Score6
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 7.84 | ||
| Debt/EBITDA | 3.83 | ||
| Cap/Depr | 22.85% | ||
| Cap/Sales | 0.86% | ||
| Interest Coverage | 3.17 | ||
| Cash Conversion | 51.78% | ||
| Profit Quality | 191.2% | ||
| Current Ratio | 2.41 | ||
| Quick Ratio | 1.73 | ||
| Altman-Z | 2.07 |
F-Score6
WACC8.35%
ROIC/WACC3.33
Cap/Depr(3y)49.26%
Cap/Depr(5y)65.23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)2.02%
Profit Quality(3y)91.71%
Profit Quality(5y)109.85%
High Growth Momentum
Growth
EPS 1Y (TTM)20.24%
EPS 3Y-25.33%
EPS 5Y-26.21%
EPS Q2Q%11.11%
EPS Next Y-0.06%
EPS Next 2Y0.71%
EPS Next 3Y0.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.8%
Revenue growth 3Y-1.47%
Revenue growth 5Y-0.1%
Sales Q2Q%-7.72%
Revenue Next Year0%
Revenue Next 2Y0.05%
Revenue Next 3Y0.21%
Revenue Next 5Y1.59%
EBIT growth 1Y47.56%
EBIT growth 3Y-7.11%
EBIT growth 5Y-7.53%
EBIT Next Year15.9%
EBIT Next 3Y4.95%
EBIT Next 5YN/A
FCF growth 1Y816.58%
FCF growth 3Y-22.26%
FCF growth 5Y-16.78%
OCF growth 1Y436.98%
OCF growth 3Y-22.52%
OCF growth 5Y-17.41%
EMBECTA CORP / EMBC FAQ
What is the fundamental rating for EMBC stock?
ChartMill assigns a fundamental rating of 6 / 10 to EMBC.
What is the valuation status for EMBC stock?
ChartMill assigns a valuation rating of 8 / 10 to EMBECTA CORP (EMBC). This can be considered as Undervalued.
Can you provide the profitability details for EMBECTA CORP?
EMBECTA CORP (EMBC) has a profitability rating of 7 / 10.
What are the PE and PB ratios of EMBECTA CORP (EMBC) stock?
The Price/Earnings (PE) ratio for EMBECTA CORP (EMBC) is 4.21 and the Price/Book (PB) ratio is -1.12.
Can you provide the expected EPS growth for EMBC stock?
The Earnings per Share (EPS) of EMBECTA CORP (EMBC) is expected to decline by -0.06% in the next year.